Can Asian-American Identity Still Be a Political Home?
Legacies examines the varied strategies Asian-American artists used to navigate New York from 1969 through 2001, offering lessons for the future.
The Cross-Pollination Between Prints and Textiles Yields Abundance
An exhibition at the New York Public Library shows that these modes share deep roots.
The Motley Crew of Haegue Yang’s Hybrid Sculptures
The artist explores sonic reverberations, the relationship between the sacred and material realms, and the ways in which artworks might be activated by a participant.
The Charming and Strange History of New Yorkers and Their Animals
At the New-York Historical Society, a new exhibition chronicles the lives of pets and their owners since the 18th century.
Palantir’s Stock Is Up 161% This Year. Is It Too Expensive to Buy?
The AI powerhouse looks unstoppable right now, but looks can be deceiving.
Is United Airlines Stock a Buy?
This airline giant can fly even higher.
Is Summit Therapeutics a Millionaire Maker?
The potential upside of this stock is undeniably meaty.
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Verizon, Dow, and Chevron are all well-known companies, but there are some caveats with each of these Dow Jones components.
2 High-Yield Dividend Stocks That Are Screaming Buys Right Now
Want to add reliable dividend payers to your portfolio? These household names can deliver inflation-beating payouts for many years to come.
Spousal Social Security Benefits: 3 Things All Retired Couples Should Know
Spouses of retirees who qualify for Social Security benefits can get benefits through their partner.
3 Dividend Stocks to Double Up on Right Now
While tech-based growth stocks might seem like the right play, you can’t ignore dividends if you want to have a strong portfolio.
Tesla Shares Surge on Delivery Forecast. Is It Time to Buy the Stock?
CEO Elon Musk predicts 20% to 30% delivery growth next year.
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
Novo Nordisk dominates diabetes treatment and obesity care, but one clinical-stage pharma company could be the next breakout star.
3 Wealth-Building Vanguard ETFs to Buy Hand Over Fist
These three time-tested Vanguard ETFs can supercharge your long-term wealth-building strategy.
Is Shopify Stock a No-Brainer Buy Below $100?
The company keeps putting up strong growth numbers. That doesn’t necessarily make the stock a buy.
These 7 Blunt Words Just Opened a Can of Worms For Pfizer’s Stock
The company’s problems are no longer deniable.
Why I’m Loading Up on These 3 High-Dividend ETFs for Passive Income
These ETFs provide different types of income.
Starbucks Pulls Guidance as Promotions Fail to Drive Traffic. Should Investors Worry?
The company preannounced very poor fiscal Q4 results.
Pricing Power Continues to Power Coca-Cola. Can It Last?
Should investors worry about the company’s Q3 volume declines?
This Billionaire Income Investor Prefers These Ultra-High-Yield Dividend Stocks Right Now
Bill Gross believes MLPs are really attractive right now.